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Eric Birgbauer
Biology Faculty
Member Given
$360,000 Grant
to Study the
Optic Nerve
Quick Facts
 Birgbauer wrote in his application for the three-
year grant that visual impairment is a significant
unmet medical need. Glaucoma is the second
leading cause of blindness due to damage to
Retinal Ganglion Cells (RGCs) and the optic
nerve.
 Damage to the optic nerve from injury or
disease, such as glaucoma, is permanent and
regrowth does not normally occur. However,
during embryonic growth and development of the
fetus before birth, he said, vibrant nerve growth
does occur. 
ROCK HILL, S.C. – The National Institutes of Health recently awarded a $360,000 grant
to Winthrop University biology faculty member Eric Birgbauer to continue his studies on
how the optic nerve grows and can possibly be regenerated.
Birgbauer wrote in his application for the three-year grant that visual impairment is a
significant unmet medical need. Glaucoma is the second leading cause of blindness
due to damage to Retinal Ganglion Cells (RGCs) and the optic nerve. 
Damage to the optic nerve from injury or disease, such as glaucoma, is permanent and
regrowth does not normally occur. However, during embryonic growth and development of the
fetus before birth, he said, vibrant nerve growth does occur. 
“We are using embryonic development in chickens to understand how the optic nerve grows and
connects normally to find therapies that will induce regeneration after disease or damage,” Birgbauer
said.
He added that his long-term goal will be to focus on developing therapies to induce RGC
regeneration to restore sight. His approach is to analyze the normal development of RGC axons and
the optic nerve during the time when nerve growth occurs naturally in order to obtain clues for
regenerative therapy. 
“Toward this goal, we are investigating the molecules that guide RGC axons to their correct targets.
Specifically, we are analyzing the role of a novel class of signaling molecules, the
lysophospholipids, specifically lysophosphatidic acid (LPA),” said the assistant professor of biology.
“We postulate that LPA, acting through the cognate receptor LPA4, is a guidance molecule for retinal
ganglion cell (RGC) axons during development.”
Birgbauer said undergraduate students will help in the investigation to learn analytical skills and an
understanding of the scientific process.
For more information, contact Judy Longshaw, news and media services manager, at 803/323-2404
or longshawj@winthrop.edu.
[Back to Previous Page]
EMAIL  WINGSPAN  BLACKBOARD  MAP  SITE  PEOPLE 
A-Z Site Map
Accessibility
Alumni & Friends
Arts
Board of Trustees
Calendars
Directions
Directory
Disclaimer
Emergency/Safety
Employment
Family Programs
Finance & Business
Financial Aid
Library
Majors & More
Office of the President
Online Learning (Graduate)
Records & Registration
Residence Life
Site Feedback
Tuition & Fees
Visit the Campus
Visitors Center
© Winthrop University · 701 Oakland Avenue · Rock Hill, SC 29733, USA · 803/323-2211
